Indeed, at least three of the findings by Whitworth et al. in patients with three or more primary tumours (in the genes BRCA2 and MSH2) may be classified as secondary, as they were found in individuals who had not had breast/ovarian or colorectal/endometrial cancer. This evidence concerns the gene MSH2 and endometrial cancer.